Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Novo Nordisk

So, is Wegovy the same as Ozempic? Your need-to-knows about the controversial over-the-counter weight loss drugs

Two experts explain.

Marie Claire

Revealed: maker of Wegovy ‘skinny jab’ is funding NHS weight-loss services

Critics fear conflict of interest as Novo Nordisk helps medics ‘reduce unnecessary barriers’ to treatment for obesity

The Guardian - UK

EU backs use of Novo Nordisk's weight loss drug in adolescents

The European Medicines Agency said on Friday its committee has recommended expanding the use of Danish drugmaker Novo Nordisk's weight loss drug in adolescents aged 12 years and older.

Reuters

From analysis to the latest developments in health,
read the most diverse news in one place.

How Investors are Capitalizing on the Ozempic and Wegovy Craze

Ozempic and Wegovy started as injectable diabetes treatments. But now, these “appetite suppressants” are being touted as miracle weight loss drugs.

Barchart

Stay Forever Young With These 3 Pharmaceutical Stocks

Despite macroeconomic headwinds, the pharmaceutical industry is anticipated to stay buoyed in the foreseeable future, owing to rising healthcare spending. Against this backdrop, we think the strong fundamentals of Novo Nordisk (NVO), Bristol-Myers Squibb (BMY), and Takeda Pharmaceutical (TAK) make them wise portfolio additions. Read on….

StockNews.com

WHO to consider adding obesity drugs to ‘essential’ medicines list

A panel of advisers to the WHO will review requests for drugs to be included next month

Evening Standard

Relief for diabetes sufferers with fast-acting insulin Fiasp to remain on PBS until September

Fast-acting insulin Fiasp has been a "game changer" for Daniel Webb in managing his type 1 diabetes. The drug was about to be removed from the PBS, but a temporary solution has been found.

ABC News

Read news from The Economist, FT, and more,
with one subscription

‘I skip meals to make my insulin last’: the cost of diabetes in the global south

The three firms that control the insulin market are to cut costs in the US, but elsewhere users can spend all their pay to get the life-saving drug

The Guardian - UK

Newsom announces $50 million contract to make California’s own brand of insulin

LOS ANGELES — California Gov. Gavin Newsom announced a new $50-million contract with the nonprofit generic drugmaker Civica to produce insulin under the state’s own label during a news conference Saturday in Downey.

Los Angeles Times

‘Skinny jab’ drug firm facing fresh inquiries after ‘serious breaches’ of industry code

Pharmaceutical company behind blockbuster diet jab Wegovy confronts crises on multiple fronts, amid scrutiny of UK activities

The Guardian - UK

The biggest U.S. pharmaceutical companies are lowering insulin costs to save themselves money

So much for altruism.

Axios

Anti-obesity drug demand expected to skyrocket, but will insurance cover the cost?

New weight loss drugs can cost more than $1,000 a month, but most health plans don’t cover them.

Chicago Sun-Times

Firm behind Wegovy slimming jab suspended from UK trade association

Novo Nordisk found to be in breach of ABPI code of practice over sponsored weight-loss courses that promoted its medicines

The Guardian - UK

Biden drawing contrast to Republicans on lower drug costs

President Joe Biden will highlight the stark differences in how Democrats are tackling skyrocketing drug prices compared to their Republican counterparts as he gears up for an expected reelection announcement

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

Novo Nordisk will cut some U.S. insulin prices by up to 75% starting next year

The Danish drugmaker's move follows a similar announcement by rival Eli Lilly earlier this month. More than 8 million Americans use insulin, according to the American Diabetes Association.

The Independent UK

Novo Nordisk to slash insulin price by up to 75% in push for affordable diabetes treatments

The brand is the latest to plan dramatic price cuts for the diabetes drug

Tribune News Service

Why does insulin cost so much? Big Pharma isn’t the only player driving prices

Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma.

Tribune News Service

New obesity drug would cost Medicare $27 billion, even with limited uptake

Covering Novo Nordisk A/S’s new obesity drug Wegovy could strain the budget of US government insurance program Medicare, according to a new analysis in the New England Journal of Medicine.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Revealed: experts who praised new ‘skinny jab’ received payments from drug maker

Novo Nordisk gave millions to obesity charities and healthcare professionals, including expert who advised Nice

The Guardian - UK

‘Orchestrated PR campaign’: how skinny jab drug firm sought to shape obesity debate

Maker of Wegovy, an appetite suppressor hailed as a weight-loss magic bullet, has spent millions on a slick PR campaign – including payments to some of its biggest cheerleaders

Daily Record

'Game changer' weight loss drug popular among celebrities is approved for NHS use

The appetite suppressant Wegovy, also known as semaglutide is going to be made available through the NHS and will be supplied via injection to people living with obesity.

Daily Mirror

What is Wegovy and who is eligible as NHS approves weight loss drug

A weight loss jab have been approved for use through the NHS for people with at least one weight-related condition and a BMI score of at least 35

Daily Mirror

'Game changer' weight loss drug beloved by celebrities to be available on NHS

Thousands are expected to be offered the appetite suppressant Wegovy on prescription after the National Institute for Health and Care Excellence gave the NHS the green light for it to be used

Chronicle Live

'Game changer' weight loss injection to become available on NHS for people with obesity

Health officials have announced that some people will be offered the appetite suppressant Wegovy on prescription, after approval was given for NHS use

Manchester Evening News

Wegovy weight loss drug - what is it, who is eligible to use it and when will it be available in UK?

The drug will also be available to buy privately through some pharmacies

1 … 24 25 26 27

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

BristolMyers Squibb Company

95 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.